W
WAVEMAN · COMPANY
IMUX · Immunic, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

IMUX

IMMUNIC, INC.
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001280776
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
13
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
13 funds added or opened last quarter
below 78% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
10.5% of shares outstanding short · 10.1 days to cover · settled 2026-07-31
more than 79% of Pharma & Biotech
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +59.7%
+59.7%12M
-36%+13%+62%+112%2025-092025-102025-122026-032026-052026-072026-09 2026-02-20 · BIOTECHNOLOGY VALUE FUND L P filed a 5%+ stake (7.4%)2026-02-20 · BVF I GP LLC filed a 5%+ stake (7.4%)2026-02-20 · BIOTECHNOLOGY VALUE FUND II LP filed a 5%+ stake (2.2%)2026-02-20 · BVF II GP LLC filed a 5%+ stake (2.2%)2026-02-20 · Biotechnology Value Trading Fund OS LP filed a 5%+ stake (0.3%)2026-02-20 · BVF Partners OS Ltd. filed a 5%+ stake (0.3%)2026-02-20 · BVF GP HOLDINGS LLC filed a 5%+ stake (9.6%)2026-02-20 · BVF PARTNERS L P/IL filed a 5%+ stake (9.99%)2026-02-20 · BVF INC/IL filed a 5%+ stake (9.99%)2026-02-20 · LAMPERT MARK N filed a 5%+ stake (9.99%)2026-02-20 · R. Thorvald Nagel filed a 5%+ stake
13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows 13 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for IMMUNIC, INC. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Nash Duane
Executive Chairman
BUY
2025-06-13
20,000.0
$16.6K
Tardio Jason
President and COO
BUY
2025-06-05
12,512.0
$9.9K
Tardio Jason
President and COO
BUY
2025-06-05
12,512.0
$9.9K
Neermann Joerg
Director
BUY
2025-06-05
30,000.0
$22.8K
Vitt Daniel
CEO and Director
BUY
2025-06-04
15,000.0
$11.6K
25 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 20 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Aberdeen Group plc
824,393.0 sh
$12.7M
BVF INC/IL
765,295.0 sh
$11.8M
MILLENNIUM MANAGEMENT LLC
740,347.0 sh
$11.4M
Avidity Partners Management LP
669,941.0 sh
$10.3M
BRAIDWELL LP
645,010.0 sh
$9.9M
5%+ owners
13D = intent to influence · 13G = passive
BIOTECHNOLOGY VALUE FUND L P
ACTIVIST 13D · 2026-02-20
7.4%
BVF I GP LLC
ACTIVIST 13D · 2026-02-20
7.4%
BIOTECHNOLOGY VALUE FUND II LP
ACTIVIST 13D · 2026-02-20
2.2%
BVF II GP LLC
ACTIVIST 13D · 2026-02-20
2.2%
Biotechnology Value Trading Fund OS LP
ACTIVIST 13D · 2026-02-20
0.3%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Simplify Propel Opportunities ETF
$487.2K POSITION · AS OF 2026-03-31
0.7%
iShares Micro-Cap ETF
$336.7K POSITION · AS OF 2026-03-31
0.0%
1290 VT Micro Cap Portfolio
$23.6K POSITION · AS OF 2026-03-31
0.0%
Fidelity Flex Small Cap Index Fund
$18.1K POSITION · AS OF 2026-04-30
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$1.5M POSITION · AS OF 2026-03-31
0.0%
Fidelity ZERO Extended Market Index Fund
$40.2K POSITION · AS OF 2026-04-30
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
OPERATING INCOME$-103.2M$-98.1M$-99.2M$-119.5M
NET INCOME$-97.2M$-100.5M$-93.6M$-120.4M
EPS (DILUTED)-0.62-1.00-2.11-3.78
OPERATING CASH FLOW$-85.8M$-84.8M$-70.8M$-65.1M
CASH$15.5M$35.7M$46.7M$106.7M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →